Table 2.
The longitudinal analysis of anti-PvGAMA responses in individuals during acute Plasmodium vivax infection and 3 months post-infection
| Subject | Optical density (OD) | |
|---|---|---|
| Acute phase | 3 months post-infection | |
| Pv01 | 0.405 | 0.075 |
| Pv02 | 0.427 | 0.218 |
| Pv03 | 0.864 | 0.426 |
| Pv04 | 0.395 | 0.279 |
| Pv05 | 0.134 | 0.091 |
| Pv06 | 0.086 | 0.084 |
| Pv08 | 0.363 | 0.219 |
| Pv09 | 0.362 | 0.258 |
| Pv11 | 0.081 | 0.074 |
| Pv12 | 0.090 | 0.071 |
| Pv13 | 0.086 | 0.073 |
| Pv14 | 0.080 | 0.072 |
| Pv15 | 0.081 | 0.085 |
| Pv16 | 0.616 | 0.084 |
| Pv30 | 0.116 | 0.077 |
| Pv31 | 0.494 | 0.086 |
| Pv32 | 0.221 | 0.087 |
| Pv33 | 0.082 | 0.068 |
| Pv34 | 0.138 | 0.072 |
| Pv35 | 0.096 | 0.074 |
| Pv37 | 0.805 | 0.241 |
| Pv38 | 0.081 | 0.070 |
| Pv39 | 0.379 | 0.092 |
| Pv40 | 0.544 | 0.069 |
Seropositive: the individuals who had OD values greater than or equal to the cut-off value (mean ± 2 SD of the OD value of healthy controls = 0.078)